Fred Dejonckheere
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Survival in Idiopathic Pulmonary Fibrosis: Perspectives from Pulmonary Arterial Hypertension.
Journal: Journal of managed care & specialty pharmacy
Published: March 14, 2017
Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis.
Journal: Journal of managed care & specialty pharmacy
Published: March 14, 2017
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-Analysis.
Journal: Journal of managed care & specialty pharmacy
Published: May 07, 2015
Efficacy Of Novel Dmards In Early Active Rheumatoid Arthritis: An Indirect Comparison.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK.
Journal: PharmacoEconomics
Published: May 24, 2014
Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analysis.
Journal: Health and quality of life outcomes
Published: January 13, 2014
Economic evaluation of tocilizumab monotherapy compared to adalimumab monotherapy in the treatment of severe active rheumatoid arthritis.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: October 14, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026